Compare ARK Genomic Revolution ETF (ARKG) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs State Street PDR S&P Retail ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while State Street PDR S&P Retail ETF trades at $88.59. Which is the better fit depends on your goals.
| ARKG | XRT | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $90.88 |
52-Week Low | $23.09 | $77.28 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XRT trades at $88.08, up 1.33% today, amid mixed technical signals with a bearish overall trend but bullish moving averages. The ETF faces headwinds from negative consumer sentiment and inflation pressures, though retail sales have shown resilience. Recent news highlights analyst caution due to macro risks, with a downgrade to Hold noted by Seeking Alpha on May 19, 2026.
Outlook is cautious; attractive valuation near 16x earnings per recent analysis is offset by consumer spending pressures. Risks include high gas prices and real wage declines, but potential exists if bargain-focused retail strategies gain traction. Investors should weigh technical weakness against fundamental value in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
